Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001939509 | SCV002231935 | pathogenic | Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD | 2021-11-18 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PRKCD-related conditions. For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp105*) in the PRKCD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRKCD are known to be pathogenic (PMID: 11976687, 23319571, 23430113). |
Gene |
RCV002269381 | SCV002552824 | uncertain significance | not provided | 2022-01-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Center for Genomic Medicine, |
RCV001939509 | SCV005374415 | uncertain significance | Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD | 2024-09-22 | criteria provided, single submitter | clinical testing |